The really big Institutional buying won't occur till the Market Cap is dramatically higher, probably at stock prices at $5. Institutions which formally are chartered not to invest in stocks below a certain market cap or stock price frequently do get in, but then they get out before the end of the quarter unless the price goes above their threashold by the end of the quarter. Institutions only report what they hold for over the end of a quarter if it hasn't been held for a full quarter or more. An institution buying in October can sell on December 31st and not report at all, or if they do report I won't show until Mid February. While computers would permit all this to be done instantaneously, the rules permit Institutions not to report until half way through the next quarter. By the time Investors know what's really happened the news could potentially be as much as 4.5 months old if an Institution made it's move on the first day of a quarter.
It's my belief that by the time AEZS is $8 it will probably be 50% of more Institutionally owned. While some of these shares may come from newly authorized share, the overwhelming majority will come from individual investors selling.
I believe those who'll make the most money on this stock are probably not currently invested in its. If Perifosine and AEZS-108 are both successful, don't be satisfied with a 10 banger, in a few years it could be a 100 banger or more.
Gary
Market Data 
Markets 
AI
